Skip to content

    Breast Cancer Health Center

    Font Size
    A
    A
    A

    Drugs Prevent Breast Cancer -- for Some

    Few Now Benefit; Safer Drugs Needed
    By
    WebMD Health News
    Reviewed by Gary D. Vogin, MD

    July 1, 2002 -- There's no doubt that new drugs called SERMs can prevent breast cancer. The problem is that nobody's quite sure how to use them -- yet.

    The drugs are tamoxifen (sold as Nolvadex) and Evista. They are drugs that act like estrogen on some cells in the body and in other cells block the action of estrogen. Clinical trials show that both drugs can prevent breast cancers that need estrogen to grow. So far, the FDA has approved only tamoxifen for breast cancer prevention. Evista is FDA approved for treating bone loss after menopause.

    Eli Lilly and Company, the maker of Evista, is a WebMD sponsor.

    A team of distinguished breast cancer experts took a look at all clinical trials of the two drugs. Their report -- upon which the U.S. Preventive Services Task Force will base its official recommendations -- appears in the July 2 issue of Annals of Internal Medicine. Lead author Linda Kinsinger, MD, MPH, is co-director of the prevention program at the University of North Carolina School of Medicine in Chapel Hill.

    "The bottom line is that these medicines offer some promising opportunities," Kinsinger tells WebMD. "The target group is still small, no more than 10% of women in general. The drugs are not for everyone. But for one group -- women generally in their 40s to 50s with increased risk of breast cancer but who don't have increased risk for the drugs' side effects -- these women should talk with their doctors about them."

    European studies failed to find a prevention benefit for tamoxifen. While Kinsinger and her fellow experts can't entirely explain this, they suggest that too few women in these studies took the drug long enough for maximum effect. Also, these studies may have had too few women with estrogen-sensitive breast cancer.

    A large U.S. study got much different results. It looked at more than 13,000 women age 35 or older with a relatively high risk of breast cancer. It showed that tamoxifen cut breast cancer risk in half. To prevent one case of breast cancer, the study showed, 47 women would have to take tamoxifen for five years.

    Today on WebMD

    Breast Cancer Overview
    From mammograms to living after treatment.
    Dealing with breast cancer
    Get answers to your questions.
     
    woman having mammogram
    The 3 latest tips to know.
    woman undergoing breast cancer test
    Most abnormalities aren’t breast cancer.
     
    Resolved To Quit Smoking
    VIDEO
    Breast Cancer Treatments Improving
    Article
     
    Woman getting mammogram
    Article
    Screening Tests for Women
    Article
     
    serious woman
    Article
    Pink badge on woman chest to support breat cancer
    QUIZ
     
    what is your cancer risk
    Article
    breast cancer survivors
    Article